Abstract
Background: There is evidence that the adaptive or acquired immune system is one of the crucial variables in differentiating the course of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This work aimed to analyze the immunopathological aspects of adaptive immunity that are involved in the progression of this disease.
Methods: This is a systematic review based on articles that included experimental evidence from in vitro assays, cohort studies, reviews, cross-sectional and case-control studies from PubMed, SciELO, MEDLINE, and Lilacs databases in English, Portuguese, or Spanish between January 2020 and July 2022.
Results: Fifty-six articles were finalized for this review. CD4+ T cells were the most resolutive in the health-disease process compared with B cells and CD8+ T lymphocytes. The predominant subpopulations of T helper lymphocytes (Th) in critically ill patients are Th1, Th2, Th17 (without their main characteristics) and regulatory T cells (Treg), while in mild cases there is an influx of Th1, Th2, Th17 and follicular T helper cells (Tfh). These cells are responsible for the secretion of cytokines, including interleukin (IL) – 6, IL-4, IL-10, IL-7, IL-22, IL-21, IL-15, IL-1α, IL-23, IL-5, IL-13, IL-2, IL-17, tumor necrosis factor alpha (TNF-α), CXC motivating ligand (CXCL) 8, CXCL9 and tumor growth factor beta (TGF-β), with the abovementioned first 8 inflammatory mediators related to clinical benefits, while the others to a poor prognosis. Some CD8+ T lymphocyte markers are associated with the severity of the disease, such as human leukocyte antigen (HLA-DR) and programmed cell death protein 1 (PD-1). Among the antibodies produced by SARS-CoV-2, Immunoglobulin (Ig) A stood out due to its potent release associated with a more severe clinical form.
Conclusions: It is concluded that through this study it is possible to have a brief overview of the main immunological biomarkers and their function during SARS-CoV-2 infection in particular cell types. In critically ill individuals, adaptive immunity is varied, aberrantly compromised, and late. In particular, the T-cell response is also an essential and necessary component in immunological memory and therefore should be addressed in vaccine formulation strategies.
Keywords: COVID-19; SARS-CoV-2; adaptive immunity; humoral immunity; immunity.
【저자키워드】 COVID-19, SARS-CoV-2, Adaptive immunity, Humoral immunity, immunity., 【초록키워드】 coronavirus disease, Necrosis, Vaccine, coronavirus, Biomarker, Cytokines, adaptive, Immunity, cross-sectional, SARS-COV-2 infection, severity, T-cell Response, Th1, Th2, Th17, systematic review, progression, immune system, Cohort studies, Immunological memory, database, Antigen, B cell, Protein, lymphocyte, Critically ill, Regulatory T cell, Characteristics, Alpha, CXCL9, IL-10, disease, HLA-DR, CD4+ T cell, Treg, TNF-α, Tfh, IL-2, case-control study, IL-21, IL-7, IL-15, marker, IL-13, IL-4, TGF-β, IL-22, Evidence, Ligand, CD8+ T lymphocytes, humoral, IL-17, cell types, T helper cell, leukocyte, tumor growth, Critically ill patient, programmed cell death, T helper, acute respiratory syndrome, clinical benefits, secretion, poor prognosis, T lymphocyte, article, IL-5, IL-1α, CD8+, subpopulation, experimental evidence, IL-23, variable, Spanish, immunological, Cell, English, inflammatory mediator, SciELO, Course, produced, responsible, caused, involved, the disease, individuals, predominant, addressed, immunopathological, follicular, in vitro assays, mild case, the antibody, 【제목키워드】 systematic review,